Amanote Research
Register
Sign In
MYEOV (Myeloma Overexpressed (In a Subset of T(11;14) Positive Multiple Myelomas))
Atlas of Genetics and Cytogenetics in Oncology and Haematology
- France
doi 10.4267/2042/47277
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Genetics
Hematology
Date
May 1, 2012
Authors
J Moreaux
Publisher
INIST-CNRS
Related search
Successful Venetoclax Salvage in the Setting of Refractory, Dialysis-Dependent Multiple Myeloma With T(11;14)
Haematologica
Hematology
Translocation T(11;14) (Q13;q32) and Genomic Imbalances in Multi-Ethnic Multiple Myeloma Patients: A Malaysian Study
Hematology Reports
Hematology
MYEOV (Myeloma Overexpressed Gene) Drives Colon Cancer Cell Migration and Is Regulated by PGE2
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
The CCND1 C.870G>A Polymorphism Is a Risk Factor for T(11;14)(q13;q32) Multiple Myeloma
Nature Genetics
Genetics
Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory T(11;14) Multiple Myeloma
British Journal of Haematology
Hematology
Rituximab in CD20 Positive Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
MB4-2 Breakpoint in MMSET Combined With Del(17p) Defines a Subset of T(4;14) Multiple Myeloma With Very Poor Prognosis
Haematologica
Hematology
Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma
Journal of Cancer
Oncology
Bone Marrow Endothelial Cells Sustain a Tumor-Specific CD8+ T Cell Subset With Suppressive Function in Myeloma Patients
OncoImmunology
Oncology
Allergy
Immunology